Deals & business · 7h ago Alphabet and Meta now spend nearly as much on R&D as pharma’s 10 largest drugmakers 1 outlet Johnson & Johnson Roche
Deals & business · 9h ago New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™ 1 outlet
Deals & business · 11h ago Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact 1 outlet Eli Lilly
Deals & business · 13h ago Ligand, AvenCell ink financing deal worth up to $47M for CAR-T therapies 1 outlet CAR-T & cell therapy
Deals & business · 14h ago Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore 1 outlet Sanofi
Deals & business · 14h ago Lilly extends China innovation push in $3.35B Innocare deal 1 outlet Eli Lilly
Deals & business · 17h ago Anthropic-, Nvidia-Backed Basecamp Research Raise $140M Series C Financing Toward Advancing AI-Designed Drugs 2 outlets
Deals & business · 14h ago Merck reveals study success, and possible safety worries, for eye drug hopeful 1 outlet Merck & Co. (MSD)
Deals & business · 17h ago Roche inks up to $2B deal with Atavistik for new cardiometabolic drugs 2 outlets Roche
Deals & business · 16h ago Arcturus raised to Buy at Citi after mid-stage trial data for liver disease drug 1 outlet
Deals & business · 16h ago Daiichi Sankyo expands Turbine collaboration to accelerate ADC discovery 1 outlet Antibody-drug conjugates Daiichi Sankyo
Deals & business · 16h ago Lilly’s latest China drug deal; Immunovant’s setback in lupus 1 outlet Eli Lilly Vertex
Deals & business · 17h ago Aqua Medical Secures Series B Funding to Advance U.S. Pivotal Trial for Novel Through-the-Scope Type 2 Diabetes Procedure 1 outlet
Deals & business · 20h ago InnoCare inks licensing deal with Eli Lilly worth up to $3.35B 2 outlets Eli Lilly
Deals & business · 18h ago Lakewood-Amedex Biotherapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of Nu-3 for Infected Diabetic Foot Ulcers 1 outlet
Deals & business · 18h ago Atossa Therapeutics CEO Dr. Steven Quay to Participate in ARDD 2026 Panel on Clinical Trials and Regulatory Pathways for Diseases of Aging 1 outlet
Deals & business · 18h ago Pharma sector revenue to grow 11-13 pc in FY27 on strong exports, domestic demand: Crisil 1 outlet
Deals & business · 19h ago Eli Lilly and InnoCare Pharma agree on $3.3bn drug research deal 1 outlet Eli Lilly
Deals & business · 19h ago What the revised 340B rebate pilot programme means for pharma revenue operations 1 outlet
Deals & business · 22h ago Podcast: More meaningful partnerships spurring on Chinese biotechs 1 outlet
Deals & business · yesterday Growth mode: 3 biotechs that are staffing up after series B raises 1 outlet Eli Lilly Johnson & Johnson
Deals & business · yesterday Lilly puts up $100M, plus billions on the backend, to form 5-target deal with China's InnoCare 1 outlet Eli Lilly
Deals & business · yesterday AbbVie: Revenue Pressure And Weakening Earnings Support A 'Sell' 1 outlet AbbVie
Deals & business · yesterday BoomRay and Novartis sign $900m deal for radioligand therapy 4 outlets Novartis